Evicenter
MarkdownMedical informationP&T meetings
Lysergide (DT120)

Generalized anxiety disorder

Also known as MM120
Launch
Not announced
Last updated
199 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatment

Heterogeneity of treatment effect

12 evidence topics · 11 sources

DT120 in Voyage: change in HAM-A score at Week 12 by subgroup
SubgroupPlacebo-adjusted LS mean change (SE)
All participants“−5.4 (1.0)”
Time since GAD symptoms began, less than 22 years (n = 107)“−5.9 (1.4)”
Time since GAD symptoms began, 22 years or more (n = 107)“−4.7 (1.5)”
Previous GAD medications, fewer than 2 (n = 136)“−4.2 (1.2)”
Previous GAD medications, 2 or more (n = 78)“−5.6 (1.7)”
Male (n = 77)“−7.1 (1.7)”
Female (n = 137)“−5.5 (1.2)”